Recent studies have revealed that the inhibition of autophagy by FIP200 ablation suppresses mammary tumor initiation and progression, and Wang et al. established the prognostic significance of ATG5 and FIP200 in patients with breast cancer [48]. This evidence concerns the gene ATG5 and breast carcinoma.